Craig-Hallum raised the firm’s price target on Koru Medical (KRMD) to $5 from $4 and keeps a Buy rating on the shares. The firm notes Koru Medical reported Q3 ahead of expectations, with guidance raised and importantly, cash flow breakeven reiterated for Q4.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KRMD:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue